# Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors

> **NCT02452710** · NA · TERMINATED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 40 (actual)

## Conditions studied

- Fatigue in Cancer Survivors

## Interventions

- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02452710
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2017-02-01
- **Final completion:** 2017-02-01
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Study funding was completed.
- **Last updated:** 2018-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452710, "Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02452710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*